Cytomed Therapeutics Limited Stock Technical Analysis
GDTC Stock | 2.55 0.17 7.14% |
As of the 22nd of January, CytoMed Therapeutics shows the Downside Deviation of 7.73, risk adjusted performance of 0.058, and Mean Deviation of 6.01. CytoMed Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
CytoMed Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as CytoMed, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CytoMedCytoMed |
CytoMed Therapeutics Analyst Consensus
Target Price | Advice | # of Analysts | |
5.0 | Strong Buy | 1 | Odds |
Most CytoMed analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand CytoMed stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of CytoMed Therapeutics, talking to its executives and customers, or listening to CytoMed conference calls.
CytoMed Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
CytoMed Therapeutics Technical Analysis
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of CytoMed Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
CytoMed Therapeutics Trend Analysis
Use this graph to draw trend lines for CytoMed Therapeutics Limited. You can use it to identify possible trend reversals for CytoMed Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual CytoMed Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.CytoMed Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for CytoMed Therapeutics Limited applied against its price change over selected period. The best fit line has a slop of 0.01 , which means CytoMed Therapeutics Limited will continue generating value for investors. It has 122 observation points and a regression sum of squares at 1.24, which is the sum of squared deviations for the predicted CytoMed Therapeutics price change compared to its average price change.About CytoMed Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of CytoMed Therapeutics Limited on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of CytoMed Therapeutics Limited based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on CytoMed Therapeutics price pattern first instead of the macroeconomic environment surrounding CytoMed Therapeutics. By analyzing CytoMed Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of CytoMed Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to CytoMed Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 57.75 | 257.2 | 231.48 | 243.06 | PTB Ratio | 72.61 | 6.13 | 7.05 | 6.7 |
CytoMed Therapeutics January 22, 2025 Technical Indicators
Most technical analysis of CytoMed help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for CytoMed from various momentum indicators to cycle indicators. When you analyze CytoMed charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | 0.058 | |||
Market Risk Adjusted Performance | 0.3172 | |||
Mean Deviation | 6.01 | |||
Semi Deviation | 7.13 | |||
Downside Deviation | 7.73 | |||
Coefficient Of Variation | 1721.88 | |||
Standard Deviation | 8.71 | |||
Variance | 75.87 | |||
Information Ratio | 0.0539 | |||
Jensen Alpha | 0.4531 | |||
Total Risk Alpha | 0.2225 | |||
Sortino Ratio | 0.0607 | |||
Treynor Ratio | 0.3072 | |||
Maximum Drawdown | 60.9 | |||
Value At Risk | (10.60) | |||
Potential Upside | 12.99 | |||
Downside Variance | 59.71 | |||
Semi Variance | 50.91 | |||
Expected Short fall | (6.89) | |||
Skewness | 1.02 | |||
Kurtosis | 5.1 |
CytoMed Therapeutics January 22, 2025 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as CytoMed stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 12,631 | ||
Daily Balance Of Power | 0.32 | ||
Rate Of Daily Change | 1.07 | ||
Day Median Price | 2.59 | ||
Day Typical Price | 2.57 | ||
Price Action Indicator | 0.05 |
Complementary Tools for CytoMed Stock analysis
When running CytoMed Therapeutics' price analysis, check to measure CytoMed Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CytoMed Therapeutics is operating at the current time. Most of CytoMed Therapeutics' value examination focuses on studying past and present price action to predict the probability of CytoMed Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CytoMed Therapeutics' price. Additionally, you may evaluate how the addition of CytoMed Therapeutics to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |